Molecular Biology Enzymes & Kits & Reagents Market Report 2025

The molecular biology enzymes & kits & reagents market size has grown rapidly in recent years. It will grow from $20.87 billion in 2024 to $24 billion in 2025 at a compound annual growth rate (CAGR) of 15%. The growth in the historic period can be attributed to genomic research advancements, biotechnology industry growth, diagnostic and therapeutic advancements, focus on genomic sequencing, advancements in cloning techniques.

The molecular biology enzymes & kits & reagents market size is expected to see rapid growth in the next few years. It will grow to $44.3 billion in 2029 at a compound annual growth rate (CAGR) of 16.6%. The growth in the forecast period can be attributed to automation and high-throughput solutions, regenerative medicine focus, tissue engineering applications, RNA interference techniques. Major trends in the forecast period include biotechnology and life sciences growth, PCR-based technologies, proteomics advancements, drug discovery applications, stem cell research expansion, collaborations and research funding.

The increasing prevalence of infectious diseases is anticipated to drive the growth of the molecular biology enzymes, kits, and reagents market. Infectious diseases are illnesses caused by harmful microorganisms, including bacteria, fungi, parasites, and others. Molecular biology enzymes, kits, and reagents play a crucial role in isolating and characterizing these infectious organisms, aiding in patient control and treatment. For instance, in November 2023, the New South Wales Ministry of Health, an Australian government organization, reported a significant rise in emergency department visits due to chickenpox infections, with cases increasing from 549 in 2022 to 687 in 2023, representing a 25% rise within a year. Therefore, the surge in infectious disease incidence is propelling the growth of the molecular biology enzymes, kits, and reagents market.

The expanding adoption of automation within production processes is anticipated to drive the market for molecular biology enzymes, kits, and reagents. Automation, employing technology such as robotics, streamlines manufacturing operations and bolsters demand for these tools. For instance, as per a report from Manufacturing India in March 2022, India's manufacturing industries are witnessing widespread adoption of automation. Projections suggest that by 2050, around 85-90% of manufacturing firms in India will have embraced automation. This trend is expected to significantly contribute to the growth of the nucleic acid isolation and purification market.

Technological innovation is a prominent trend gaining traction in the molecular biology enzymes, kits, and reagents market. Major players in the industry are developing cutting-edge technologies to expedite disease identification by eliminating bottlenecks in the diagnostic process. Such advancements allow these companies to secure a competitive advantage. For example, in June 2022, Altona Diagnostics, a Germany-based healthcare and diagnostics firm, introduced the RealStar Zoonotic Orthopoxvirus PCR Kit 1.0. This diagnostic tool is specifically designed to detect zoonotic orthopoxviruses, which can be transmitted from animals to humans. Utilizing real-time polymerase chain reaction (PCR) technology, the kit amplifies and identifies specific DNA sequences linked to orthopoxviruses, facilitating quick and accurate detection in both clinical and research environments. It is particularly important for monitoring zoonotic diseases and supporting public health initiatives. The kit comes with all necessary reagents and is compatible with various sample types, making it a valuable resource for laboratories focused on infectious diseases.

Major players in the market for molecular biology enzymes, kits, and reagents prioritize strategic partnerships to advance their objectives. These collaborations involve resource-sharing to foster mutual growth. As seen in February 2023, Ultima Genomics, Inc partnered with New England Biolabs Inc to enhance next-generation sequencing (NGS) procedures for DNA, RNA, and methylation sequencing applications. Such alliances allow companies to combine expertise and resources for technological advancements.

In January 2023, QIAGEN N.V., a manufacturing company based in Germany, acquired Verogen for $150 million. This acquisition aims to strengthen QIAGEN's position as a leader in the rapidly expanding field of human identification and forensics by integrating next-generation sequencing (NGS) technologies. The integration is intended to enhance tools and services used in forensic investigations and missing-person cases. Verogen, a biotechnology company located in the United States, specializes in forensic DNA analysis and molecular diagnostics.

Major companies operating in the molecular biology enzymes & kits & reagents market are Thermo Fisher Scientific Inc., Merck & Co. Inc., Promega Corporation, New England Biolabs Inc., Illumina Inc., Takara Bio USA Holdings Inc., QIAGEN, Agilent Technologies Inc., F Hoffmann-La Roche AG, Bio-Rad Laboratories Inc., LGC Group, Jena Bioscience GmbH, Molecular Biology Resources Inc., Integrated DNA Technologies Inc., Randox Laboratories, ADS Biotec Inc., Goldsite Diagnostics Inc., GE Healthcare, Lucigen Corporation, Bio Basic Inc., Bioo Scientific Corporation, Bioline, Biotechrabbit GmbH, BioWORLD, Epicentre, Hamilton Company, Omega Bio-tek, Sigma-Aldrich, Zymo Research, Abcam plc.

North America was the largest region in the molecular biology enzymes, kits, and reagents market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the molecular biology enzymes & kits & reagents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the molecular biology enzymes & kits & reagents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Molecular biology enzymes, kits, and reagents are fundamental in the extraction and isolation of DNA or RNA fragments from complex nucleic acid mixtures. They play a crucial role in drug discovery, clinical investigations, and the development of candidate drug molecules. These tools are extensively utilized by pharmaceutical companies for tasks like cloning, RNA and DNA analysis and sequencing, as well as DNA isolation and protein analysis.

The primary products within the domain of molecular biology enzymes, kits, and reagents include enzymes like polymerases, ligases, restriction endonucleases, reverse transcriptase, and others. These kits and reagents find extensive use in molecular diagnostics, genetic disease diagnosis, gene analysis, and molecular fingerprinting. They serve as substances or tools enabling the identification of microorganisms in samples, applied across various fields such as sequencing, cloning, PCR, epigenetics, restriction digestion, and numerous other applications. These tools see utilization in academic and research institutes, pharmaceutical and biotechnology companies, hospitals and diagnostic centers, and various other end-user segments.

The molecular biology enzymes and kits and reagents market research report is one of a series of new reports that provides molecular biology enzymes and kits and reagents market statistics, including molecular biology enzymes and kits and reagents industry global market size, regional shares, competitors with a molecular biology enzymes and kits and reagents market share, detailed molecular biology enzymes and kits and reagents market segments, market trends and opportunities, and any further data you may need to thrive in the molecular biology enzymes and kits and reagents industry. This molecular biology enzymes, kits, and reagents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The molecular biology enzymes, kits, and reagents market consists of sales of terminal deoxynucleotidyl transferees, modified bacteriophage T7 DNA polymerase, and T4 DNA polymerase. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.